The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma

Insights into the biology of advanced renal cell carcinoma (aRCC) and the development of agents targeting the vascular endothelial growth factor (VEGF) pathway have positively impacted the outcomes for patients with aRCC. With the recent approval of the dual immune checkpoint inhibitors (ICIs), nivo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Asim Amin, Hans Hammers
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019-01-01
Series:Frontiers in Immunology
Assuntos:
combination immunotherapy
VEGF inhibition
immune check point inhibitor
advanced renal cell carcinoma
immuno modulation
Acceso en liña:https://www.frontiersin.org/article/10.3389/fimmu.2018.03120/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares